Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
26.2%
% of BBP's 65 holdings also in PBE
57.1%
% of PBE's 28 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 5.1% | 2.1% |
|
HALOZYME THERAPEUTICS INC | 2.1% | 3.1% | 2.1% |
|
TG THERAPEUTICS INC | 2.1% | 3.8% | 2.1% |
|
AMGEN INC | 2.0% | 5.0% | 2.0% |
|
PTC THERAPEUTICS INC | 1.8% | 3.0% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to PBE
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% |
|
SAGE THERAPEUTICS INC | 2.2% |
|
AXSOME THERAPEUTICS, INC. | 2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.1% |
|
BRIDGEBIO PHARMA, INC. | 1.9% |
|
ASCENDIS PHARMA A/S | 1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 1.7% |
BBP Underweight Relative to PBE
|
NATERA INC | -4.7% |
|
ILLUMINA INC | -4.3% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.9% |
|
NEUROCRINE BIOSCIENCES INC | -3.5% |
|
BIOGEN IDEC INC | -3.4% |
|
CATALYST PHARMACEUTICAL PART | -3.3% |
|
AMGEN INC | -3.0% |
|
GILEAD SCIENCES INC | -3.0% |
|
UNITED THERAPEUTICS CORP | -3.0% |
|
REGENERON PHARMACEUTICALS | -3.0% |